https://www.fredhutch.org/en/news/releases/rss2015-08-05T03:03:15.128ZNews Releases RSS FeedAdobe Experience ManagerFred Hutch’s Obliteride will soon spin through Western Washingtonhttps://www.fredhutch.org/en/news/releases/2015/07/Obliteride-will-spin-through-western-washington2015-07-28T18:11:52.000Z2015-07-28T18:11:52.000ZScience teachers devote summer vacation to boosting science educationMore than 21 science teachers from communities across Washington are spending part of their summer vacation at “school,” working beside scientists in research laboratories at Fred Hutchinson Cancer Research Center and partner sites throughout Seattle. Now in its 25th year, Fred Hutch’s Science Education Partnership, or SEP, provides local teachers with the opportunity to expand their science knowledge and curriculum with hands-on training in Fred Hutch’s and partnering institution’s research labs.https://www.fredhutch.org/en/news/releases/2015/07/science-teachers-devote-summer-vacation-boosting-science-education2015-07-08T23:27:53.000Z2015-07-08T23:27:53.000ZFred Hutch researcher Rainer Storb receives $12.9 million to study immunotherapies, gene therapies to improve treatments for sickle-cell anemia, “bubble boy” disease and related conditionsRainer Storb, M.D., head of the Transplantation Biology Program at Fred Hutchinson Cancer Research Center, has received a $12.9 million grant from the National Heart, Lung, and Blood Institute to improve treatments for patients with inborn diseases of the immune system and red blood cells. https://www.fredhutch.org/en/news/releases/2015/07/fred-hutch-researcher-rainer-storb-receives-grant2015-07-07T23:08:25.000Z2015-07-07T23:08:25.000ZCyrus Ghajar receives $4.1M grant to study ways to prevent metastatic breast cancerCyrus Ghajar, Ph.D., a metastatic breast cancer researcher at Fred Hutchinson Cancer Research Center, has received a $4.1 million Department of Defense Breast Cancer Research Program (BCRP) “Era of Hope” Scholar Award.https://www.fredhutch.org/en/news/releases/2015/06/cyrus-ghajar-gets-4-million-dollar-grant-to-study-metastatic-breast-cancer2015-06-29T17:50:19.000Z2015-06-29T17:50:19.000ZWeight loss, combined with vitamin D, reduces inflammation linked to cancer, chronic diseaseFor the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight loss, in combination with vitamin D supplementation, has a greater effect on reducing chronic inflammation than weight loss alone. Chronic inflammation is known to contribute to the development and progression of several diseases, including some cancers.https://www.fredhutch.org/en/news/releases/2015/06/weight-loss-plus-vitamin-d-reduces-inflammation2015-06-24T20:54:38.000Z2015-06-24T20:54:38.000ZNCI funds $3.1M Fred Hutch clinical trial of a smoking-cessation smartphone appDr. Jonathan Bricker, a behavioral scientist at Fred Hutchinson Cancer Research Center and the University of Washington, has received a $3.1 million, five-year grant from the National Cancer Institute to conduct a randomized, controlled clinical trial of SmartQuit, a smoking-cessation smartphone app.https://www.fredhutch.org/en/news/releases/2015/06/nci-funds-clinical-trial-of-quit-smoking-app2015-06-19T18:13:00.000Z2015-06-19T18:13:00.000ZFred Hutch names Matthew Trunnell as its vice president and chief information officerhttps://www.fredhutch.org/en/news/releases/2015/06/fred-hutch-names-matthew-trunnell-as-vp-cio2015-06-16T23:56:00.000Z2015-06-16T23:56:00.000ZVirus evolution and human behavior shape global patterns of flu movementThe global movement patterns of all four seasonal influenza viruses are illustrated in research published today in the journal Nature, providing a detailed account of country-to-country virus spread over the last decade and revealing unexpected differences in circulation patterns between viruses.
https://www.fredhutch.org/en/news/releases/2015/06/virus-evolution-human-behaviour-shape-global-patterns-flu-movement2015-06-08T16:01:30.000Z2015-06-08T16:01:30.000ZFred Hutch recruits Niki Robinson as Vice President of Industry Relations and Business Developmenthttps://www.fredhutch.org/en/news/releases/2015/06/fred-hutch-recruits-niki-robinson-vp-industry-relations-business-development2015-06-04T20:00:58.000Z2015-06-04T20:00:58.000ZPuget Sound-area Hispanic/Latino cancer survivors needed for Fred Hutch Research StudyPuget Sound-area Hispanic/Latino cancer survivors are needed to participate in support groups as part of a Fred Hutchinson Cancer Research Center study called SANA: Survivors Helping Each Other Navigate Forward, or “Sobrevivientes Apoyándose a Navegar Adelante.” The goal of the study is to learn more about the needs of Hispanics/Latinos who have survived cancer. https://www.fredhutch.org/en/news/releases/2015/06/hispanic-latino-cancer-survivors-needed-for-study2015-06-02T23:04:00.000Z2015-06-02T23:04:00.000ZFred Hutch researchers present at ASCO 2015 Annual meetingA number of investigators from Fred Hutchinson Cancer Research Center will share new research findings at the annual meeting of the American Society of Clinical Oncology, or ASCO, which is being held May 29–June 2 in Chicago. The theme of this year’s gathering is “Illumination & Innovation: Transforming Data into Learning.”https://www.fredhutch.org/en/news/releases/2015/05/fred-hutch-researchers-present-at-asco2015-05-29T16:19:53.000Z2015-05-29T16:19:53.000ZFred Hutch and Uganda Cancer Institute open UCI-Fred Hutch Cancer Centre in Kampalahttps://www.fredhutch.org/en/news/releases/2015/05/fred-hutch-uganda-cancer-institute-open-cancer-centre-in-kampala2015-05-21T21:11:00.000Z2015-05-21T21:11:00.000ZFred Hutch Researchers discover tumor molecule that causes spread of pancreatic cancerA single molecule switches on metastasis, or spread, in pancreas cancers, reports new research led by scientists at Fred Hutchinson Cancer Research Center. The researchers predict that testing for this molecule, called RUNX3, could very soon help oncologists choose the most appropriate treatments based on the metastatic potential of each patient’s disease.https://www.fredhutch.org/en/news/releases/2015/05/researchers-discover-tumor-molecule-spread-pancreatic-cancer2015-05-21T15:53:25.000Z2015-05-21T15:53:25.000ZFred Hutch geneticist and biologist Sue Biggins selected as a Howard Hughes Medical Institute investigator Sue Biggins, Ph.D., a geneticist and biologist at Fred Hutchinson Cancer Research Center who studies the machinery that dividing cells use to ensure their daughter cells receive the correct allotment of chromosomes, has been selected to become a Howard Hughes Medical Institute investigator. She is among 26 of the nation’s top biomedical scientists to receive the honor this year out of a pool of nearly 900 applicants.https://www.fredhutch.org/en/news/releases/2015/05/fred-hutch-researcher-sue-biggins-selected-hhmi-investigator2015-05-19T17:58:13.000Z2015-05-19T17:58:13.000ZSpace Needle, in partnership with Fred Hutchinson Cancer Research Center, opens registration for first public stair climb in the landmark’s historyhttps://www.fredhutch.org/en/news/releases/2015/05/space-needle-fred-hutch-first-public-stair-climb2015-05-07T19:14:56.000Z2015-05-07T19:14:56.000ZNew technique allows researchers to see gene activity in single cells in a living animal for the first timeFor the first time, researchers can see and reliably measure how genes turn on and off in individual cells in a living animal — and they can track that gene activity through the animal’s entire life. This new technique, described in a paper published Wednesday in the journal PLOS ONE, will allow researchers to explore heretofore unanswered questions about the role of random variation in cancer and aging, said Fred Hutchinson Cancer Research Center molecular biologist Roger Brent, Ph.D., who led the study.
https://www.fredhutch.org/en/news/releases/2015/05/technique-allows-researchers-see-gene-activity2015-05-06T22:16:41.000Z2015-05-06T22:16:41.000ZNobel Laureate and Fred Hutch researcher Linda Buck elected to Royal SocietyNobel Laureate Linda Buck, Ph.D., researcher at Fred Hutchinson Cancer Research Center, has been elected to the Royal Society as a foreign member.https://www.fredhutch.org/en/news/releases/2015/05/linda-buck-elected-to-royal-society2015-05-01T15:41:01.000Z2015-05-01T15:41:01.000ZGenetic counseling linked to increased use of preventive ovary removal in women at high risk for ovarian cancerA randomized clinical trial conducted by M. Robyn Andersen, Ph.D., M.P.H., and colleagues at Fred Hutch has found, for the first time, that proactively offering genetic counseling to women at high risk of ovarian cancer can increase the use of prophylactic oophorectomy, or preventive ovary removal.https://www.fredhutch.org/en/news/releases/2015/04/genetic-counseling-increases-preventive-ovary-removal2015-04-24T17:29:29.000Z2015-04-24T17:29:29.000ZStudy finds that microinjection platform enables assessment of multiple cancer drugs directly in tumors, predicts systemic responseA newly developed technology for simultaneously comparing response to multiple cancer drugs or combinations while a tumor is still in a patient’s body has been shown to accurately predict systemic response to the drugs, according to researchers at Fred Hutchinson Cancer Research Center and Presage Biosciences. The patented technology, called CIVO™, consists of an arrayed microinjection drug delivery device and quantitative analysis methodology.https://www.fredhutch.org/en/news/releases/2015/04/microinjection-platform-enables-assessment-multiple-cancer-drugs2015-04-22T07:00:00.000Z2015-04-22T07:00:00.000ZObesity significantly increases prostate cancer risk in African-American men, study findshttps://www.fredhutch.org/en/news/releases/2015/04/obesity-ups-prostate-cancer-risk-in-black-men2015-04-16T16:27:08.000Z2015-04-16T16:27:08.000Z